Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Fuji
Baxter
Julphar
Queensland Health
Argus Health
Accenture
Fish and Richardson
Chinese Patent Office

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022128

« Back to Dashboard

NDA 022128 describes SELZENTRY, which is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from four suppliers. There are four patents protecting this drug and one Paragraph IV challenge. Additional details are available on the SELZENTRY profile page.

The generic ingredient in SELZENTRY is maraviroc. There are two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the maraviroc profile page.
Summary for 022128
Tradename:SELZENTRY
Applicant:Viiv Hlthcare
Ingredient:maraviroc
Patents:4
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 022128
Suppliers and Packaging for NDA: 022128
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SELZENTRY maraviroc TABLET;ORAL 022128 NDA Pfizer Laboratories Div Pfizer Inc 0069-0807 E 0069-0807-60
SELZENTRY maraviroc TABLET;ORAL 022128 NDA Pfizer Laboratories Div Pfizer Inc 0069-0808 E 0069-0808-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength150MG
Approval Date:Aug 6, 2007TE:RLD:Yes
Regulatory Exclusivity Expiration:Nov 4, 2019
Regulatory Exclusivity Use:NEW PATIENT POPULATION
Regulatory Exclusivity Expiration:Nov 4, 2019
Regulatory Exclusivity Use:NEW STRENGTH
Patent:➤ Sign UpPatent Expiration:Dec 1, 2019Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Covington
US Department of Justice
Cerilliant
McKesson
Johnson and Johnson
Daiichi Sankyo
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot